Pathologic fibrosis and matrix connective tissue in the subaortic myocardium of patients with hypertrophic cardiomyopathy

Department of Pathology, Albert Einstein College of Medicine, Bronx, New York 10461.

To evaluate scar-type and matrix connective tissue and to assess their role in the diastolic dysfunction of hypertrophic cardiomyopathy, surgically resected subaortic myectomy specimens and several autopsy hearts from patients with hypertrophic cardiomyopathy were studied. Eighteen specimens were differentially stained by a newly developed method that precisely determines relative collagen content; these tissues were compared with postmortem hypertrophied and normal control subaortic specimens. Quantitation revealed a 72% higher level (36.5 vs. 22.1 micrograms collagen/mg protein) of stainable collagen in the hearts with hypertrophic cardiomyopathy than in hypertrophied control hearts. The endocardial plaque was quantitated morphometrically, and it constituted only 4.6 +/- 1.7% of the total increased collagen content in the cardiomyopathy specimens. For the matrix studies, the cardiomyopathy specimens were stained by a silver impregnation technique that identifies connective tissue elements not normally visible with routine histologic methods. There was a marked increase in content of all matrix components, both in areas of pathologic scarring and in "normal" zones. Whorls of matrix connective tissue were noted in regions of myocyte whorls, as well as independent of them. Thus, these studies revealed a striking increase of both scar-type and matrix connective tissue in hypertrophic cardiomyopathy. The extensive scarring and the pronounced interstitial and intercellular matrix connective tissue may contribute to the increased ventricular chamber stiffness and impaired relaxation in this disease.

This article has been cited by other articles:

				A. H. Aletras, G. S. Tilak, L.-Y. Hsu, and A. E. Arai Heterogeneity of Intramural Function in Hypertrophic Cardiomyopathy: Mechanistic Insights From MRI Late Gadolinium Enhancement and High-Resolution Displacement Encoding With Stimulated Echoes Strain Maps Circ Cardiovasc Imaging, July 1, 2011; 4(4): 425 - 434. [Abstract] [Full Text] [PDF]

				E. Sueyoshi, I. Sakamoto, and M. Uetani Contrast-Enhanced Myocardial Inversion Time at the Null Point for Detection of Left Ventricular Myocardial Fibrosis in Patients With Dilated and Hypertrophic Cardiomyopathy: A Pilot Study Am. J. Roentgenol., April 1, 2010; 194(4): W293 - W298. [Abstract] [Full Text] [PDF]

				M. S. Maron, I. Olivotto, B. J. Maron, S. K. Prasad, F. Cecchi, J. E. Udelson, and P. G. Camici The Case for Myocardial Ischemia in Hypertrophic Cardiomyopathy J. Am. Coll. Cardiol., August 25, 2009; 54(9): 866 - 875. [Abstract] [Full Text] [PDF]

				F. Cambronero, F. Marin, V. Roldan, D. Hernandez-Romero, M. Valdes, and G. Y.H. Lip Biomarkers of pathophysiology in hypertrophic cardiomyopathy: implications for clinical management and prognosis Eur. Heart J., January 9, 2009; (2009) ehn538v1. [Abstract] [Full Text] [PDF]

				B. Sotgia, R. Sciagra, I. Olivotto, G. Casolo, L. Rega, I. Betti, A. Pupi, P. G. Camici, and F. Cecchi Spatial Relationship Between Coronary Microvascular Dysfunction and Delayed Contrast Enhancement in Patients with Hypertrophic Cardiomyopathy J. Nucl. Med., July 1, 2008; 49(7): 1090 - 1096. [Abstract] [Full Text] [PDF]

				B. Pinamonti, A. Di Lenarda, G. Nucifora, D. Gregori, A. Perkan, and G. Sinagra Incremental prognostic value of restrictive filling pattern in hypertrophic cardiomyopathy: a Doppler echocardiographic study Eur Heart J Cardiovasc Imaging, July 1, 2008; 9(4): 466 - 471. [Abstract] [Full Text] [PDF]

				A. S. Adabag, B. J. Maron, E. Appelbaum, C. J. Harrigan, J. L. Buros, C. M. Gibson, J. R. Lesser, C. A. Hanna, J. E. Udelson, W. J. Manning, et al. Occurrence and Frequency of Arrhythmias in Hypertrophic Cardiomyopathy in Relation to Delayed Enhancement on Cardiovascular Magnetic Resonance J. Am. Coll. Cardiol., April 8, 2008; 51(14): 1369 - 1374. [Abstract] [Full Text] [PDF]

				A. Ralph-Edwards, A. Woo, B. W. McCrindle, J. L. Shapero, L. Schwartz, H. Rakowski, E. D. Wigle, and W. G. Williams Hypertrophic obstructive cardiomyopathy: Comparison of outcomes after myectomy or alcohol ablation adjusted by propensity score J. Thorac. Cardiovasc. Surg., February 1, 2005; 129(2): 351 - 358. [Abstract] [Full Text] [PDF]

				L. Choudhury, H. Mahrholdt, A. Wagner, K. M. Choi, M. D. Elliott, F. J. Klocke, R. O. Bonow, R. M. Judd, and R. J. Kim Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy J. Am. Coll. Cardiol., December 18, 2002; 40(12): 2156 - 2164. [Abstract] [Full Text] [PDF]

				B. J. Maron Hypertrophic Cardiomyopathy: A Systematic Review JAMA, March 13, 2002; 287(10): 1308 - 1320. [Abstract] [Full Text] [PDF]

				M. Guazzi, A. Maltagliati, G. Tamborini, F. Celeste, M. Pepi, M. Muratori, M. Berti, and M. D. Guazzi How the left and right sides of the heart, as well as pulmonary venous drainage, adapt to an increasing degree of head-up tilting in hypertrophic cardiomyopathy: differences from the normal heart J. Am. Coll. Cardiol., July 1, 2000; 36(1): 185 - 193. [Abstract] [Full Text] [PDF]

				J. Shirani, R. Pick, W. C. Roberts, and B. J. Maron Morphology and significance of the left ventricular collagen network in young patients with hypertrophic cardiomyopathy and sudden cardiac death J. Am. Coll. Cardiol., January 1, 2000; 35(1): 36 - 44. [Abstract] [Full Text] [PDF]

				M. K. Gol, M. Emir, T. Keles, S. A. Kucuker, C. L. Birincioglu, Y. H. Karagoz, T. Kural, O. Tasdemir, S. Goksel, and K. Bayazit Septal Myectomy in Hypertrophic Obstructive Cardiomyopathy: Late Results With Stress Echocardiography Ann. Thorac. Surg., September 1, 1997; 64(3): 739 - 745. [Abstract] [Full Text]

				P. R. Fox, S.-K. Liu, and B. J. Maron Echocardiographic Assessment of Spontaneously Occurring Feline Hypertrophic Cardiomyopathy : An Animal Model of Human Disease Circulation, November 1, 1995; 92(9): 2645 - 2651. [Abstract] [Full Text]

				E. D. Wigle, H. Rakowski, B. P. Kimball, and W. G. Williams Hypertrophic Cardiomyopathy : Clinical Spectrum and Treatment Circulation, October 1, 1995; 92(7): 1680 - 1692. [Full Text]